FH Europe News

FHchol celebrates its 10th anniversary

FHchol celebrates its 10th anniversary

On Friday, November 19th, FHchol’s members came together at an annual meeting and celebrated the organization’s 10th anniversary. It was a hybrid event, allowing the members to join online, or in person for the first time in a long time, and just before a new...

Welcome to new members

Welcome to new members

Our Network continues to grow! We are delighted to see a growing interest among international heart and cardiovascular diseases (CVD) patient organizations in supporting actively people living with familial hypercholesterolaemia and other hereditary dyslipidaemias,...

Heart Beat News – October 2021

Heart Beat News – October 2021

Read the October edition of FH Europe’s Heart Beat newsletter: In this edition: Read our Patient Stories, highlighting our courageous network of patient advocates sharing their unique stories and experiences of living with FH, HoFH, Lp(a) and FCS. Learn about the...

Help us save lives – Become an FH Europe Trustee

Help us save lives – Become an FH Europe Trustee

Charity Trustee Role (Volunteer) Help us to save lives. FH Europe is a young, yet very successful, energetic and ambitious patient network. We represent 26 patient organisations across 25 European countries  and continue to grow. Our purpose is to improve Europe-wide...

Post technical meeting statement on FH paediatric screening

Post technical meeting statement on FH paediatric screening

FH paediatric screening in the EU and the wider Europe is achievable, with the right political will, smart investment and genuine partnership that include patients and citizens as equal players. The overriding message from the high-level technical meeting on FH...

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design